SPIA
ORTX

Steward Partners Investment Advisory’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Steward Partners Investment Advisory’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100
Closed -$1K – 3420
2022
Q1 		$1K Hold
100
– – ﹤0.01% 3246
2021
Q4 		$1K Buy
+100
New +$1.65K ﹤0.01% 3147

Other funds holding ORTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Steward Partners Investment Advisory's ORTX Position: Q2 2022 in Review

Steward Partners Investment Advisory sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q2 2022, closing a stake of 100 shares — an estimated $1K sold.

Steward Partners Investment Advisory first reported a position in ORTX in Q4 2021 and held it in 2 quarters. The position peaked at $1K in Q1 2022. 50 funds tracked by Wall St. Rank hold ORTX as of Q2 2022.

  • Steward Partners Investment Advisory reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q2 2022 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 100 Orchard Therapeutics plc American Depositary Shares shares in Q2 2022, an estimated $1K.
  • Steward Partners Investment Advisory first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2021 and held it in 2 quarters.
  • Steward Partners Investment Advisory's Orchard Therapeutics plc American Depositary Shares position peaked at $1K in Q1 2022.
  • 50 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q2 2022.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2022, filed 4 Aug 2022.